Sean Hall | CEO
Sean was one of the founders of FIT-BioCeuticals LTD (www.fit-bioceuticals.com.au) and through Mr. Hall’s management and guidance, BioCeuticals (leading brand) expanded into a leadership role in the Australian Health Care community. Supported by novel research, FIT-BioCeuticals developed innovative products that were both patentable and coveted on the world stage.
Due to the market positioning and leadership of the BioCeuticals range, Mr. Hall sold his interest in FIT-BioCeuticals LTD in July 2012 at a premium rate (14.5 x P.E & 10 x EBITDA). Mr. Hall started Medlab in August 2012, which focuses on research and development for new drugs in the area of biologics.
Australian born Sean Hall has over 20 years experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the USA. Sean’s focus on leadership and innovation has led to the authoring of multiple patents, written peer reviewed articles and lectures at scientific conferences. His passion is in research and leading research teams into novel areas and strong commercialization opportunities.
Sean is the current CEO of Medlab Australia, specializing in early phase drug development in Biologics and bacteria identification. He is also a Board Member of the International Probiotics Association (IPA). He is the 2012 Finalist Australian Growth Company Awards, CEO Exit of the Year for his trade sale to Blackmores. Sean joins InMed Technologies because of his belief in designing therapeutic formulations that are clinically relevant to today’s patient.